Q:
How many manuscript submissions does the Journal
receive each year? From where do they come?
A:
The Journal receives more than 5000 article submissions each year, an average of approximately 18 submissions each business day. About two-thirds of our research submissions come from outside the United States.
Q:
What is the Ingelfinger Rule?
A:
The rule requires that author-researchers not release the details
of their findings to the mass media before their work undergoes peer
review and is published. Most medical journals have similar rules.
The Ingelfinger Rule was instituted by the Journal in 1969 for two reasons: to allow time for the independent peer review of scientific findings before public dissemination and to protect the originality of content. Discussion of results in poster sessions or at professional meetings is permitted under our policy. For more details about our editorial policies, please see Published Editorials on Journal Policy.
Q:
What is the Journal’s mailing address?
A:
For contact information, please see Contact
Us.
Q:
What is the Journal’s telephone
number?
A:
For contact information, please see Contact
Us.
Q:
Who is on the Journal’s Editorial
Board?
A:
A current list of the members of the Editorial Board of the Journal
can be found at http://www.nejm.org/aboutnejm/edboard.asp.
Q:
When is the Journal published?
A:
The Journal is published weekly, with a Thursday publication
date. Each week’s content is made available online at
www.nejm.org at 5 p.m. Eastern Time in the United States on Wednesday.
Q:
What is the Journal’s impact factor?
A:
The Journal’s most recent (2006) impact factor was 51.296. Impact factor is a measure of the number of times papers published
in the previous two years have been cited in the scientific literature.
Impact factors for all major journals are calculated by the Institute
for Scientific Information.
Q:
How many readers does the Journal have?
A:
The Journal has the largest paid circulation among medical
journals, with almost 200,000 paying subscribers. It is printed
simultaneously each week in the United States, Canada, the Netherlands, and
Japan, and a selection of translated articles reaches approximately
140,000 physicians in China through the China Medical Tribune.
Online, the Journal reaches between 300,000 and 400,000 readers each week; the Journal is also provided online at no charge
in approximately 120 economically disadvantaged countries.
Studies published in the Journal receive extensive coverage
in the news media worldwide, reaching millions of additional health
care professionals and patients each week.
Q:
What is the press embargo policy?
A:
Like most medical journals, the Journal employs an embargo
system. Copies are delivered or made available over the Internet the
Friday before publication to journalists who agree not to publish
stories before Wednesday at 5 p.m. Eastern Time in the United States.
There are two fundamental reasons for our embargo: it gives the media
time to report accurately on complex and important new research findings,
and it allows subscribers to read and understand the full reports
in the Journal before media reports prompt patients to call
with questions.
If an article has immediate clinical importance, the Journal
may designate it for “early release” and publish it at www.nejm.org
before its appearance in print.
